SciELO - Scientific Electronic Library Online

 
vol.29 issue1Inflamatory polyps of the colon an evaluationRefractary corticosteroids colonic Crohn disease with sucesful remision with infliximab author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista de Gastroenterología del Perú

Print version ISSN 1022-5129

Abstract

BARISIO D´ANGELO, María Gabriela; MARIEL ACTIS, Andrea  and  OUTOMURO, Delia. Non alcoholic fatty liver: a frequent entity with an unknown outcome. Rev. gastroenterol. Perú [online]. 2009, vol.29, n.1, pp.44-50. ISSN 1022-5129.

Non-alcoholic fatty liver disease (NAFLD), defined as excessive fat accumulation into the hepatocytes, has a prevalence of approximately 15 to 25%. Frequently associated risk factors for NAFLD are obesity, type 2 diabetes and dyslipidemia. It has been proposed that a mitochondrial dysfunction would play a crucial role in the disease development. On the other hand, focus is on insulin resistance syndrome, the only metabolic alteration strongly associated with this malady. The disease is suspected in individuals with insulin resistance characteristics such as metabolic syndrome and also in those with augmented serum aminotransferases levels. Different tests with biochemical markers have been proposed to predict the development of fibrosis or steatohepatitis. Therapeutic options in NAFLD patients are limited and weight lost remains as the most recommended one.

Keywords : NAFLD; NASH; insulin resistance; Steato Test; Fibro Test.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )